Clinical Trials

Clinical Trial Detail

Return to search results.

Phase III, Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High-Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Research Study Number       ANBL0032
Principal Investigator       Julie Park, MD
Phase       III

Look up trial at NIH

Research Study Number       ANBL0032
Contact       Seattle Children's Outpatient Attending MD
Telephone       (206) 987-2106
Other URLs that may be
of interest include

Neuroblastoma; Solid Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials